Art

J-GLOBAL ID：201702221572487415   Reference number：17A0111413

Pathophysiology and clinical management of pain in Parkinson’s disease: Differences in efficacy of dopamine agonists and deep brain stimulation

Parkinson病における疼痛の病態生理と臨床管理:ドパミンアゴニストと深部脳刺激の有効性の違い

Author (4)： Wupuer Sidikejiang (Medical Affairs, Otsuka Pharmaceutical Co., Ltd.) ,  Wupuer Sidikejiang (Division of Applied System Neuroscience, Department of Neurological Surgery, Nihon University School of Medicine) ,  Yamamoto Takamitsu (Division of Applied System Neuroscience, Department of Neurological Surgery, Nihon University School of Medicine) ,  Fukaya Chikashi (Division of Applied System Neuroscience, Department of Neurological Surgery, Nihon University School of Medicine)
Material： Pain Research  (Journal of the Japanese Association for the Study of Pain)
Volume： 31  Issue： 3  Page： 135-146(J-STAGE)  Publication year： 2016 
JST Material Number： L0995A  ISSN： 0915-8588  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： Deep Brain Stimulation

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0111413&from=J-GLOBAL&jstjournalNo=L0995A") }}

Author keywords (4)： Parkinson’s disease ,  Pain ,  Dopamine agonist ,  Deep Brain Stimulation

JST classification (1)： Treatment for nervous system diseases in general  (GN05010N)

Substance index (2)： L-Dopa ,  N-0923

Reference (90)：

• 1) Albaugh, D.L., Shih, Y.Y., Neural circuit modu­la­tion during deep brain stimulation at the subthalamic nucleus for Parkinson’s disease: what have we learned from neuroimaging studies?, Brain Connect., 4 (2014) 1-14.
• 2) Alloway, K.D., Smith, J.B., Watson, G.D., Thalamostriatal projections from the medial posterior and parafascicular nuclei have distinct topographic and physiologic properties, J. Neurophysiol., 111(2014) 36-50.
• 3) Antonini, A., Odin P., Pros and cons of apomorphine and L-dopa continuous infusion in advanced Parkinson’s disease, Parkinsonism Relat. Disord., 15 (2009) S97-100.
• 4) Antonini, A., Tolosa, E., Mizuno, Y., Yamamoto, M., Poewe, W.H., A reassessment of risks and benefits of dopamine agonists in Parkinson’s disease, Lancet Neurol., 8 (2009) 929-937.
• 5) Apkarian, A.V., Bushnell, M.C., Treede, R.D., Zubieta, J.K., Human brain mechanisms of pain perception and regulation in health and disease, Eur. J. Pain, 9 (2005) 463-484.

Terms in the title (6)： Parkinson病 ,  疼痛 ,  病態生理 ,  臨床管理 ,  ドパミンアゴニスト ,  深部脳刺激